According to the Lancet Commission’s report on prostate cancer, as life expectancy rises, the number of deaths from the disease is predicted to double, from 1.4 million in 2020 to 2.9 million in 2040. This will increase the likelihood that men will receive a prostate cancer diagnosis.
Over the same period, it is predicted that annual mortality will increase by 85% to about 700,000, mostly among men in low- and middle-income countries (LMICs).
Prostate cancer is the second most common cause of cancer-related deaths among males in the UK. Additionally, in over half of the world’s nations, it is the most prevalent type of cancer in men.
Given that the primary risk factors—being 50 years of age or older and having a family history of the disease—cannot be avoided, the study supports early detection programs for high-risk individuals.
It also emphasizes how critical it is to increase public awareness of the illness, which causes 15% of all malignancies in men.
